Inactive Instrument
DECHRA PHARMACEUTICALS LIMITED Stock OTC Markets
Stocks
DPHAY
US2434351043
OTC Markets Traded| Market Cap | 4.4B 5.77B 5.26B 4.87B 8.26B 539B 8.65B 58.85B 23.34B 291B 21.66B 21.2B 923B | P/E 2022 |
64.8x | P/E 2023 | -150x |
|---|---|---|---|---|---|
| Enterprise Value | 4.83B 6.34B 5.77B 5.34B 9.07B 592B 9.49B 64.59B 25.62B 320B 23.77B 23.27B 1,013B | EV / Sales 2022 |
5.8x | EV / Sales 2023 | 6.08x |
| Free-Float |
-
| Yield 2022 |
1.3% | Yield 2023 | 0.34% |
| 1 day | +1.98% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2024-06-09 | |
Paul Sandland
DFI | Director of Finance/CFO | 46 | 2019-04-02 |
Jamie Adams
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Sandland
BRD | Director/Board Member | 46 | 2019-10-29 |
Lawson Macartney
BRD | Director/Board Member | 68 | 2016-11-30 |
Lisa Jane Bright
BRD | Director/Board Member | 59 | 2019-01-31 |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 682M 894M 814M 754M 1.28B 83.47B 1.34B 9.11B 3.61B 45.1B 3.35B 3.28B 143B | 762M 998M 909M 842M 1.43B 93.22B 1.5B 10.18B 4.04B 50.38B 3.74B 3.67B 160B |
| Net income | 58.2M 76.29M 69.51M 64.34M 109M 7.12B 114M 778M 309M 3.85B 286M 280M 12.2B | -27.9M -36.57M -33.32M -30.84M -52.34M -3.42B -54.78M -373M -148M -1.85B -137M -134M -5.85B |
| Net Debt | 208M 273M 249M 230M 391M 25.49B 409M 2.78B 1.1B 13.77B 1.02B 1B 43.63B | 430M 564M 514M 475M 807M 52.65B 844M 5.75B 2.28B 28.45B 2.12B 2.07B 90.13B |
Employees
-
Sector
-
















